An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer.

CONCLUSIONS: A simple molecular classification for endometrioid endometrial cancers that can be easily combined with Lynch syndrome screening provides important prognostic information. These findings support prospective clinical validation and further studies on the predictive value of a simplified molecular classification system.
PMID: 29132872 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - November 10, 2017 Category: Cancer & Oncology Authors: Cosgrove CM, Tritchler DL, Cohn DE, Mutch DG, Rush CM, Lankes HA, Creasman WT, Miller DS, Ramirez NC, Geller MA, Powell MA, Backes FJ, Landrum LM, Timmers C, Suarez AA, Zaino RJ, Pearl ML, DiSilvestro PA, Lele SB, Goodfellow PJ Tags: Gynecol Oncol Source Type: research